ZA908521B - Vaccine composition with non-immunosuppressive t cell epitope component - Google Patents

Vaccine composition with non-immunosuppressive t cell epitope component

Info

Publication number
ZA908521B
ZA908521B ZA908521A ZA908521A ZA908521B ZA 908521 B ZA908521 B ZA 908521B ZA 908521 A ZA908521 A ZA 908521A ZA 908521 A ZA908521 A ZA 908521A ZA 908521 B ZA908521 B ZA 908521B
Authority
ZA
South Africa
Prior art keywords
immunosuppressive
vaccine composition
cell epitope
epitope component
component
Prior art date
Application number
ZA908521A
Other languages
English (en)
Inventor
Howard Etlinger
Etlinger Howard
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA908521B publication Critical patent/ZA908521B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA908521A 1989-10-31 1990-10-24 Vaccine composition with non-immunosuppressive t cell epitope component ZA908521B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898924438A GB8924438D0 (en) 1989-10-31 1989-10-31 Vaccine composition

Publications (1)

Publication Number Publication Date
ZA908521B true ZA908521B (en) 1991-07-31

Family

ID=10665428

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA908521A ZA908521B (en) 1989-10-31 1990-10-24 Vaccine composition with non-immunosuppressive t cell epitope component

Country Status (8)

Country Link
EP (1) EP0429816A1 (fr)
JP (1) JPH03173830A (fr)
AU (1) AU637841B2 (fr)
CA (1) CA2027317A1 (fr)
GB (1) GB8924438D0 (fr)
IE (1) IE903899A1 (fr)
NZ (1) NZ235780A (fr)
ZA (1) ZA908521B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043057A (en) * 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
US6419931B1 (en) * 1991-08-26 2002-07-16 Epimmune Inc. Compositions and methods for eliciting CTL immunity
US6322789B1 (en) 1991-08-26 2001-11-27 Epimmune, Inc. HLA-restricted hepatitis B virus CTL epitopes
US5422427A (en) * 1991-09-17 1995-06-06 The United States Of America As Represented By The United States Department Of Health And Human Services Pneumococcal fimbrial protein A
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6312944B1 (en) 1991-11-14 2001-11-06 The United States Of America As Represented By The Department Of Health And Human Services Pneumococcal fimbrial protein A
WO1993010238A1 (fr) * 1991-11-14 1993-05-27 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Vaccins a base de proteine a de pili pneumococcique
US6689363B1 (en) 1992-01-29 2004-02-10 Epimmune Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
US7611713B2 (en) 1993-03-05 2009-11-03 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide compositions
WO1995005454A1 (fr) * 1992-02-22 1995-02-23 Cambridge Bacteriophage Technologies Ltd. Bacteriophages mis au point par genie genetique et vaccins les contenant
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
IL105503A (en) * 1992-04-28 1999-05-09 Astra Ab Carbon peptide couplets capable of eliciting an immune response of T cells
KR950702635A (ko) 1992-07-31 1995-07-29 크리스틴 헬렌 수덴 감쇠 박테리아에서 재조합 융합 단백질의 발현(Expression of recombinant fusion proteins in attenuated bacteria)
DK140992D0 (da) * 1992-11-24 1992-11-24 Ole Buchardt Fremgangsmaade til frembringelse af antistoffer mod haptener og andre b-celle-antigener, antistoffer opnaaet ved fremgangsmaaden og anvendelse af disse antistoffer til fremstilling af vacciner, isaer til veterinaermedicinsk brug
US9266930B1 (en) 1993-03-05 2016-02-23 Epimmune Inc. Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions
EP0708656B1 (fr) * 1993-04-27 2002-07-31 United Biomedical, Inc. Peptides immunogenes de la lhrh et stimulators d'immunite universelle de synthese pour vaccins
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
JPH09510437A (ja) * 1993-12-28 1997-10-21 カイロン ミモトープス プロプライエトリー リミテッド Ｔ細胞エピトープ
US5573916A (en) * 1994-05-19 1996-11-12 Coretech, Inc. Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
WO1996030049A2 (fr) * 1995-03-31 1996-10-03 Immulogic Pharmaceutical Corporation Conjugues vecteurs de haptene utilises dans une therapie contre l'usage de drogues
US5840307A (en) * 1995-03-31 1998-11-24 Immulogic Pharmacuetical Corp. Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
US5876727A (en) * 1995-03-31 1999-03-02 Immulogic Pharmaceutical Corporation Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
US7709002B1 (en) * 1996-04-19 2010-05-04 The United States Of America As Represented By The Department Of Health And Human Services Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes
WO1997040156A1 (fr) 1996-04-19 1997-10-30 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Peptides ras ayant subi une mutation et servant a generer des lymphocytes t cytotoxiques cd8?+¿
CA2249409C (fr) * 1997-01-21 2010-10-26 Max Planck Gesellschaft Zur Forderung Der Wissenschaften E.V. Fragment de protease iga1 en tant que peptide vehicule
US20040087020A1 (en) 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
PT1849860E (pt) * 1997-05-28 2011-02-23 Novartis Vaccines & Diagnostic Processo de preparação de um factor imunogénico de corynebacterium diphtheriae utilizando um meio de cultura com extracto de levedura como fonte de aminoácidos e sem complexos proteicos de origem animal
GB9808932D0 (en) 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein
AU1661201A (en) 1999-11-18 2001-05-30 Epimmune, Inc. Heteroclitic analogs and related methods
US7026443B1 (en) 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
CA2328356A1 (fr) 1999-12-22 2001-06-22 Itty Atcravi Vehicules recreatifs
US7645743B2 (en) 1999-12-22 2010-01-12 Altermune, Llc Chemically programmable immunity
US7462354B2 (en) 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
AU2005291058B2 (en) * 2004-10-01 2011-09-29 Midatech Limited Nanoparticles comprising antigens and adjuvants and immunogenic structure
WO2010129666A1 (fr) 2009-05-05 2010-11-11 Altermune Technologies, Llc Immunité chimiquement programmable

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE109008T1 (de) * 1988-02-01 1994-08-15 Praxis Biolog Inc T-zellen-epitope als träger für einen konjugierten impfstoff.
GB8812214D0 (en) * 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
ES2055785T3 (es) * 1989-01-17 1994-09-01 Eniricerche Spa Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.

Also Published As

Publication number Publication date
IE903899A1 (en) 1991-05-08
AU6557190A (en) 1991-05-09
AU637841B2 (en) 1993-06-10
JPH03173830A (ja) 1991-07-29
NZ235780A (en) 1993-04-28
CA2027317A1 (fr) 1991-05-01
EP0429816A1 (fr) 1991-06-05
GB8924438D0 (en) 1989-12-20

Similar Documents

Publication Publication Date Title
ZA908521B (en) Vaccine composition with non-immunosuppressive t cell epitope component
HK35697A (en) Cyclosporin compositions
EP0419274A3 (en) Ionomer composition
HK1000113A1 (en) Vaccine composition
GB2224205B (en) Cyclosporin ophthalmic compositions
GB8911569D0 (en) Antifreeze compositions
EP0411788A3 (en) External sorting using virtual storage
GB8811948D0 (en) Composition & use
IL100953A0 (en) Lyophilized mammalian sperm cell compositions and methods for the preparation thereof
ZA902776B (en) Antidiarrhoeal composition
GB8902549D0 (en) Fuel compositions
EP0299942A3 (en) Antifreeze composition
EP0320257A3 (en) Compositions for use with fabrics
EP0386359A3 (en) Konjak-containing composition
AP9000165A0 (en) Vaccine composition
GB2231575B (en) Command-curable composition
GB8823621D0 (en) Compositions containing cyclosporins
ZW9690A1 (en) Composition
GB8902548D0 (en) Fuel compositions
HU204716B (en) Raney-catalyzer composition
GB8807393D0 (en) Composition & use
GB8818562D0 (en) Composition & use
GB8801995D0 (en) Copolymer composition
GB8803035D0 (en) Copolymer composition
RO105651B1 (ro) Compozitie medicamentoasa cu actiune antidiabetica